Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurofibromatosis 1 1Neurofibromatoses 1

Interventions

Specimen Handling 24Biopsy 16Magnetic Resonance Spectroscopy 15Cyclophosphamide 5Bevacizumab 4Vincristine 3Taxes 3Prednisone 3Nivolumab 3Doxorubicin 3Cetuximab 3Azacitidine 3venetoclax 2trastuzumab deruxtecan 2prednylidene 2olaparib 2iadademstat 2deltacortene 2decitabine and cedazuridine drug combination 2X-Rays 2Surgical Procedures, Operative 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Radiation 2Practice Guidelines as Topic 2Paclitaxel 2Ipilimumab 2Immunoglobulin G 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Lasers, Solid-State × 30 days × Clear all
NCT06934928 2026-06-04

Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs)

Massachusetts General Hospital

Phase NA Suspended
10 enrolled
CNS

Neurofibromatosis 1, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡